Yuki Kawaji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuki Kawaji has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Masahiro Itonaga
Second Department of Internal Medicine Wakayama Medical University Wakayama Japan
10 shared publications - Masayuki Kitano
Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan
10 shared publications - Takashi Tamura
Second Department of Internal Medicine Wakayama Medical University Wakayama Japan
7 shared publications - Yasunobu Yamashita
Second Department of Internal Medicine Wakayama Medical University Wakayama Japan
7 shared publications - Reiko Ashida
Second Department of Internal Medicine Wakayama Medical University Wakayama Japan
5 shared publications - Keiichi Hatamaru
Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan
4 shared publications
Latest Publications
- 2 October 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (10)
Experimental Evaluation of Novel Two‐Dimensional Endoscopic Ultrasound Shear Wave Elastography: A Phantom‐Based Study
Point shear wave elastography (SWE) can indicate tissue elasticity using absolute values, but it remains difficult to determine which areas are suitable for measurement. Recently, two‐dimensional endoscopic ultrasound SWE (2D‐EUS‐SWE), which allows visual assessment of appropriate measurement locations, has become possible. However, it remains unclear how to set the measurement and color regions of interest (ROIs) appropriately. This study aimed to evaluate the optimal ROI settings for 2D‐EUS‐SWE under various measurement conditions with phantom. Two types of commercially available elasticity phantoms were used to evaluate 2D‐EUS‐SWE. The conditions were set for five parameters: measurement ROI size, color ROI size, color ROI depth, degree of probe pressure, and color ROI angle. Measurements were performed 10 times for each setting. In a tumor model, the color ROI was set over or within the tumor. Reproducibility and reliability were then evaluated for each setting. Setting the color ROI at a depth range of 1–3 cm was found to be appropriate. The measurements were possible regardless of the color and measurement ROI sizes. When the color ROI was positioned directly below (0°), tilting it up to 45° had no effect on the measurement. In the tumor model, measurements were possible regardless of the color ROI size. In addition to clarifying the optimal condition settings, the present findings indicate that 2D‐EUS‐SWE is an accurate and reliable method for performing measurements using EUS. However, this was conducted under phantom conditions, and future clinical evaluation is necessary.
- 2 October 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (10)
Experimental Evaluation of Novel Two‐Dimensional Endoscopic Ultrasound Shear Wave Elastography: A Phantom‐Based Study
Point shear wave elastography (SWE) can indicate tissue elasticity using absolute values, but it remains difficult to determine which areas are suitable for measurement. Recently, two‐dimensional endoscopic ultrasound SWE (2D‐EUS‐SWE), which allows visual assessment of appropriate measurement locations, has become possible. However, it remains unclear how to set the measurement and color regions of interest (ROIs) appropriately. This study aimed to evaluate the optimal ROI settings for 2D‐EUS‐SWE under various measurement conditions with phantom. Two types of commercially available elasticity phantoms were used to evaluate 2D‐EUS‐SWE. The conditions were set for five parameters: measurement ROI size, color ROI size, color ROI depth, degree of probe pressure, and color ROI angle. Measurements were performed 10 times for each setting. In a tumor model, the color ROI was set over or within the tumor. Reproducibility and reliability were then evaluated for each setting. Setting the color ROI at a depth range of 1–3 cm was found to be appropriate. The measurements were possible regardless of the color and measurement ROI sizes. When the color ROI was positioned directly below (0°), tilting it up to 45° had no effect on the measurement. In the tumor model, measurements were possible regardless of the color ROI size. In addition to clarifying the optimal condition settings, the present findings indicate that 2D‐EUS‐SWE is an accurate and reliable method for performing measurements using EUS. However, this was conducted under phantom conditions, and future clinical evaluation is necessary.
- 2 February 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (2) , e70111
Screw Spike Method With a Drill Dilator for Severe Biliary Stricture
Watch a video of this article.
- 2 February 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (2) , e70111
Screw Spike Method With a Drill Dilator for Severe Biliary Stricture
Watch a video of this article.
- Open Access
- 30 November 2025
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 58 (6) , 817-825
Self-expandable metal vs. plastic stents for preoperative biliary drainage in patients receiving neoadjuvant chemotherapy
Neoadjuvant chemotherapy (NAC) improves the rate of curative resection and overall prognosis in patients with resectable or borderline resectable pancreatic cancer. The treatment period from the initiation of NAC to surgery typically ranges from 2 to 6 months. In cases of malignant biliary obstruction caused by pancreatic cancer, maintaining preoperative biliary drainage (PBD) until surgery is essential to continue NAC. Minimizing adverse events related to endoscopic biliary drainage and avoiding perioperative adverse events are crucial. Plastic stents (PSs) are commonly used for PBD; however, the extended duration of PBD required for NAC increases the risk of recurrent biliary obstruction (RBO), potentially leading to discontinuation of NAC. Therefore, preventing RBO during PBD in patients with pancreatic cancer receiving NAC is important. The placement of self-expandable metal stents (SEMSs) for PBD significantly reduces the rate of RBO compared with PS placement. Although SEMS placement may increase the risk of pancreatitis or cholecystitis, its effect on postoperative outcomes is comparable to that of PS placement. Given their lower rate of RBO, SEMSs are considered more suitable than PSs for PBD in patients with pancreatic cancer receiving NAC.
- 30 November 2025
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 58 (6) , 817-825
Open AccessSelf-expandable metal vs. plastic stents for preoperative biliary drainage in patients receiving neoadjuvant chemotherapy
Neoadjuvant chemotherapy (NAC) improves the rate of curative resection and overall prognosis in patients with resectable or borderline resectable pancreatic cancer. The treatment period from the initiation of NAC to surgery typically ranges from 2 to 6 months. In cases of malignant biliary obstruction caused by pancreatic cancer, maintaining preoperative biliary drainage (PBD) until surgery is essential to continue NAC. Minimizing adverse events related to endoscopic biliary drainage and avoiding perioperative adverse events are crucial. Plastic stents (PSs) are commonly used for PBD; however, the extended duration of PBD required for NAC increases the risk of recurrent biliary obstruction (RBO), potentially leading to discontinuation of NAC. Therefore, preventing RBO during PBD in patients with pancreatic cancer receiving NAC is important. The placement of self-expandable metal stents (SEMSs) for PBD significantly reduces the rate of RBO compared with PS placement. Although SEMS placement may increase the risk of pancreatitis or cholecystitis, its effect on postoperative outcomes is comparable to that of PS placement. Given their lower rate of RBO, SEMSs are considered more suitable than PSs for PBD in patients with pancreatic cancer receiving NAC.
- Open Access
- 31 January 2025
- Published by Society of Gastrointestinal Intervention in International Journal of Gastrointestinal Intervention
- Vol. 14 (1) , 2-8
Emergent treatment using balloon-assisted ERCP versus EUS-guided drainage for acute cholangitis in patients with surgically altered anatomy
Takahiro Shishimoto, Masahiro Itonaga, Reiko Ashida, Yasunobu Yamashita, Yuki Kawaji, Takashi Tamura, Hiromu Morishita, Akiya Nakahata, Yuto Sugihara, Tomokazu Ishihara, and Masayuki Kitano. Int J Gastrointest Interv 2025;14:2-8. https://doi.org/10.18528/ijgii240070
- 31 January 2025
- Published by Society of Gastrointestinal Intervention in International Journal of Gastrointestinal Intervention
- Vol. 14 (1) , 2-8
Open AccessEmergent treatment using balloon-assisted ERCP versus EUS-guided drainage for acute cholangitis in patients with surgically altered anatomy
Takahiro Shishimoto, Masahiro Itonaga, Reiko Ashida, Yasunobu Yamashita, Yuki Kawaji, Takashi Tamura, Hiromu Morishita, Akiya Nakahata, Yuto Sugihara, Tomokazu Ishihara, and Masayuki Kitano. Int J Gastrointest Interv 2025;14:2-8. https://doi.org/10.18528/ijgii240070
- Open Access
- 31 January 2025
- Published by Society of Gastrointestinal Intervention in International Journal of Gastrointestinal Intervention
- Vol. 14 (1) , 9-14
Novel technique for endoscopic ultrasound-guided gallbladder drainage to skip the needle tract dilation step: Efficacy of a 6-mm antimigration metal stent with a thin, tapered delivery catheter
Keiichi Hatamaru, Masayuki Kitano, Masahiro Itonaga, Yasunobu Yamashita, Takashi Tamura, Yuki Kawaji, and Junya Nuta. Int J Gastrointest Interv 2025;14:9-14. https://doi.org/10.18528/ijgii240051
- 31 January 2025
- Published by Society of Gastrointestinal Intervention in International Journal of Gastrointestinal Intervention
- Vol. 14 (1) , 9-14
Open AccessNovel technique for endoscopic ultrasound-guided gallbladder drainage to skip the needle tract dilation step: Efficacy of a 6-mm antimigration metal stent with a thin, tapered delivery catheter
Keiichi Hatamaru, Masayuki Kitano, Masahiro Itonaga, Yasunobu Yamashita, Takashi Tamura, Yuki Kawaji, and Junya Nuta. Int J Gastrointest Interv 2025;14:9-14. https://doi.org/10.18528/ijgii240051
- 24 November 2022
- Published by Elsevier in Pancreatology
- Vol. 23 (1) , 35-41
Shear-wave versus strain elastography in endoscopic ultrasound for the diagnosis of chronic pancreatitis
- 24 November 2022
- Published by Elsevier in Pancreatology
- Vol. 23 (1) , 35-41
Shear-wave versus strain elastography in endoscopic ultrasound for the diagnosis of chronic pancreatitis
- Open Access
- 15 September 2020
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 14 (5) , 659-664
Utility of Elastography with Endoscopic Ultrasonography Shear-Wave Measurement for Diagnosing Chronic Pancreatitis
Yasunobu Yamashita, Kensuke Tanioka, Yuki Kawaji, Takashi Tamura, Junya Nuta, Keiichi Hatamaru, Masahiro Itonaga, Takeichi Yoshida, Yoshiyuki Ida, Takao Maekita, Mikitaka Iguchi, and Masayuki Kitano. Gut and Liver 1999;0:. https://doi.org/10.5009/gnl19170
- 15 September 2020
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 14 (5) , 659-664
Open AccessUtility of Elastography with Endoscopic Ultrasonography Shear-Wave Measurement for Diagnosing Chronic Pancreatitis
Yasunobu Yamashita, Kensuke Tanioka, Yuki Kawaji, Takashi Tamura, Junya Nuta, Keiichi Hatamaru, Masahiro Itonaga, Takeichi Yoshida, Yoshiyuki Ida, Takao Maekita, Mikitaka Iguchi, and Masayuki Kitano. Gut and Liver 1999;0:. https://doi.org/10.5009/gnl19170
- 8 June 2020
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 36 (2) , 391-396
Endoscopic ultrasonography shear wave as a predictive factor of endocrine/exocrine dysfunction in chronic pancreatitis
Background and Aim: Chronic pancreatitis (CP) leads to permanent impairment of exocrine and endocrine functions. The endoscopic ultrasonography (EUS)‐based Rosemont classification plays an important role in diagnosing CP. However, it is based on subjective judgment. In contrast, EUS shear wave measurement (EUS‐SWM) has been established to be a precise method for evaluating tissue hardness. This study aimed to evaluate the utility of EUS‐SWM in diagnosing CP and determining exocrine and endocrine dysfunctions.Methods: We evaluated 40 patients who underwent EUS‐SWM between January 2019 and January 2020. They were classified into the normal pancreas and early, probable, and definite CP groups following the Japan Pancreatic Society criteria. EUS‐SWM value was compared between the normal pancreas group and the early, probable, and definite CP groups. The relationship between EUS‐SWM value and exocrine/endocrine dysfunctions was also assessed. The cut‐off value of EUS‐SWM for diagnosing CP and exocrine/endocrine dysfunctions was investigated.Results: The EUS‐SWM value was positively correlated with the Japan Pancreatic Society criteria stages. The probable and definite CP groups had significantly higher EUS‐SWM values than the normal group. The areas under the receiver operating characteristic curve for the diagnostic accuracy of EUS‐SWM for CP, exocrine dysfunction, and endocrine dysfunction were 0.92, 0.78, and 0.63, respectively. The cut‐off values of 1.96, 1.96, and 2.34 for diagnosing CP, exocrine dysfunction, and endocrine dysfunctions had 83%, 90%, and 75% sensitivity, respectively, and 100%, 65%, and 64% specificity, respectively.Conclusions: Endoscopic ultrasonography shear wave measurement provides objective assessment and can thus be an alternative diagnostic tool for diagnosing CP and exocrine/endocrine dysfunctions.
- 8 June 2020
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 36 (2) , 391-396
Endoscopic ultrasonography shear wave as a predictive factor of endocrine/exocrine dysfunction in chronic pancreatitis
Background and Aim: Chronic pancreatitis (CP) leads to permanent impairment of exocrine and endocrine functions. The endoscopic ultrasonography (EUS)‐based Rosemont classification plays an important role in diagnosing CP. However, it is based on subjective judgment. In contrast, EUS shear wave measurement (EUS‐SWM) has been established to be a precise method for evaluating tissue hardness. This study aimed to evaluate the utility of EUS‐SWM in diagnosing CP and determining exocrine and endocrine dysfunctions.Methods: We evaluated 40 patients who underwent EUS‐SWM between January 2019 and January 2020. They were classified into the normal pancreas and early, probable, and definite CP groups following the Japan Pancreatic Society criteria. EUS‐SWM value was compared between the normal pancreas group and the early, probable, and definite CP groups. The relationship between EUS‐SWM value and exocrine/endocrine dysfunctions was also assessed. The cut‐off value of EUS‐SWM for diagnosing CP and exocrine/endocrine dysfunctions was investigated.Results: The EUS‐SWM value was positively correlated with the Japan Pancreatic Society criteria stages. The probable and definite CP groups had significantly higher EUS‐SWM values than the normal group. The areas under the receiver operating characteristic curve for the diagnostic accuracy of EUS‐SWM for CP, exocrine dysfunction, and endocrine dysfunction were 0.92, 0.78, and 0.63, respectively. The cut‐off values of 1.96, 1.96, and 2.34 for diagnosing CP, exocrine dysfunction, and endocrine dysfunctions had 83%, 90%, and 75% sensitivity, respectively, and 100%, 65%, and 64% specificity, respectively.Conclusions: Endoscopic ultrasonography shear wave measurement provides objective assessment and can thus be an alternative diagnostic tool for diagnosing CP and exocrine/endocrine dysfunctions.